Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1989-04-07
1993-10-12
Wityshyn, Michael G.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 88, 435870, 530350, 530806, 530820, 530821, A61K 3902
Patent
active
052523284
ABSTRACT:
A composition for protecting swine against mycoplasmal pneumonia caused by M. hyopneumoniae which includes at least one protein which is an M. hyopneumoniae antigen. The M. hyopneumoniae antigen is present in an amount effective for protection of swine against mycoplasmal pneumonia caused by M. hyopneumoniae. A preferred antigen is the M. hyopneumoniae 74.5 kda antigen.
REFERENCES:
patent: 4894332 (1990-01-01), Schaller et al.
Wise et al, Chemical Abstracts, vol. 107, reference #196101d, 1987.
Schaller et al, Chemical Abstracts, vol. 106, reference #143977s, 1987.
Young et al, Chemical Abstracts, vol. 106, Reference #212183y, 1987.
Klinkert et al, Chemical Abstracts, vol. 103, reference #103070x, 1985.
Ross et al, Amer. J. Vet. Ren. vol. 45, No. 10, pp. 1899-1905, 1984.
Brooks Emily
Faulds Daryl
Vishoot Mimi
Adams Harold W.
Ericson Ivan L.
Martin Marietta Energy Systems Inc.
Mohamed Abdel A.
Wityshyn Michael G.
LandOfFree
Mycoplasma hyopneumoniae antigen and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mycoplasma hyopneumoniae antigen and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mycoplasma hyopneumoniae antigen and uses therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1902764